Correlation Between AptaBio Therapeutics and Hanil Vacuum

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AptaBio Therapeutics and Hanil Vacuum at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AptaBio Therapeutics and Hanil Vacuum into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AptaBio Therapeutics and Hanil Vacuum Co, you can compare the effects of market volatilities on AptaBio Therapeutics and Hanil Vacuum and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AptaBio Therapeutics with a short position of Hanil Vacuum. Check out your portfolio center. Please also check ongoing floating volatility patterns of AptaBio Therapeutics and Hanil Vacuum.

Diversification Opportunities for AptaBio Therapeutics and Hanil Vacuum

0.56
  Correlation Coefficient

Very weak diversification

The 3 months correlation between AptaBio and Hanil is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding AptaBio Therapeutics and Hanil Vacuum Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hanil Vacuum and AptaBio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AptaBio Therapeutics are associated (or correlated) with Hanil Vacuum. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hanil Vacuum has no effect on the direction of AptaBio Therapeutics i.e., AptaBio Therapeutics and Hanil Vacuum go up and down completely randomly.

Pair Corralation between AptaBio Therapeutics and Hanil Vacuum

Assuming the 90 days trading horizon AptaBio Therapeutics is expected to generate 0.53 times more return on investment than Hanil Vacuum. However, AptaBio Therapeutics is 1.9 times less risky than Hanil Vacuum. It trades about -0.06 of its potential returns per unit of risk. Hanil Vacuum Co is currently generating about -0.04 per unit of risk. If you would invest  794,000  in AptaBio Therapeutics on October 5, 2024 and sell it today you would lose (129,000) from holding AptaBio Therapeutics or give up 16.25% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy80.33%
ValuesDaily Returns

AptaBio Therapeutics  vs.  Hanil Vacuum Co

 Performance 
       Timeline  
AptaBio Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AptaBio Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Hanil Vacuum 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hanil Vacuum Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

AptaBio Therapeutics and Hanil Vacuum Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AptaBio Therapeutics and Hanil Vacuum

The main advantage of trading using opposite AptaBio Therapeutics and Hanil Vacuum positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AptaBio Therapeutics position performs unexpectedly, Hanil Vacuum can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hanil Vacuum will offset losses from the drop in Hanil Vacuum's long position.
The idea behind AptaBio Therapeutics and Hanil Vacuum Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules